Edoardo Mannucci

Active 1998–2025

204
Papers
22,921
Citations
98
h-index
202
i10-index

Citations

Citations per year for Edoardo Mannucci1990: 2 citations1999: 2 citations2000: 9 citations2001: 7 citations2002: 10 citations2003: 16 citations2004: 18 citations2005: 30 citations2006: 48 citations2007: 63 citations2008: 101 citations2009: 152 citations2010: 188 citations2011: 155 citations2012: 221 citations2013: 334 citations2014: 290 citations2015: 283 citations2016: 259 citations2017: 189 citations2018: 248 citations2019: 689 citations2020: 686 citations2021: 724 citations2022: 630 citations2023: 441 citations2024: 720 citations2025: 377 citations2026: 12 citations1991–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,534 citing papers, 18.8% of this breakdownItaly: 966 citing papers, 11.8% of this breakdownUnited Kingdom: 629 citing papers, 7.7% of this breakdownChina: 569 citing papers, 7% of this breakdownGermany: 340 citing papers, 4.2% of this breakdownCanada: 322 citing papers, 4% of this breakdownAustralia: 302 citing papers, 3.7% of this breakdownDenmark: 220 citing papers, 2.7% of this breakdownSpain: 187 citing papers, 2.3% of this breakdownNetherlands: 174 citing papers, 2.1% of this breakdownFrance: 161 citing papers, 2% of this breakdownSweden: 150 citing papers, 1.8% of this breakdown
0%18.8%Other 31.9%

Fields

  • Medicine79%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Psychology4.6%
  • Neuroscience1.5%
  • Health Professions0.7%
  • Social Sciences0.5%
  • Other2.9%

Topics

  • Diabetes Treatment and Management11.5%
  • Hormonal and reproductive studies5.5%
  • Metabolism, Diabetes, and Cancer5.2%
  • Pancreatic function and diabetes4.2%
  • Diabetes Management and Research4.1%
  • Sexual function and dysfunction studies3.9%
  • Other65.6%

Coauthors

All papers

Open in search
  1. Safety issues with glucagon‐like peptide‐1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis): D ata from randomized controlled trials

    Authors: , , , , , , - Diabetes Obesity and Metabolism 2017 cited by 227

  2. Glucagon‐like peptide‐1 receptor agonists and risk of thyroid cancer: A systematic review and meta‐analysis of randomized controlled trials

    Authors: , , , , , , , - Diabetes Obesity and Metabolism 2023 cited by 94

  3. A Phase 2, Randomized, Dose-Finding Study of the Novel Once-Weekly Human GLP-1 Analog, Semaglutide, Compared With Placebo and Open-Label Liraglutide in Patients With Type 2 Diabetes

    Authors: , , , , , , , - Diabetes Care 2015 cited by 224

  4. Hypoprolactinemia: A New Clinical Syndrome in Patients with Sexual Dysfunction

    Authors: , , , , , , , , , , - The Journal of Sexual Medicine 2009 cited by 172

  5. Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Thomas Schaum, Diethelm Tschoepe, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban, Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro, Stobschinski de Alba, Carlos Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández and 70 more - The Lancet Diabetes & Endocrinology 2017 cited by 292

  6. Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target

    Authors: , , , , , , , - International Journal of Cardiology 2017 cited by 163

  7. Meta-analysis of Results of Testosterone Therapy on Sexual Function Based on International Index of Erectile Function Scores

    Authors: , , , , , - European Urology 2017 cited by 217

  8. Factors affecting spermatogenesis upon gonadotropin‐replacement therapy: a meta‐analytic study

    Authors: , , , - Andrology 2014 cited by 205

  9. Sodium‐glucose co‐transporter‐2 (SGLT‐2) inhibitors and cancer: A meta‐analysis of randomized controlled trials

    Authors: , , , - Diabetes Obesity and Metabolism 2019 cited by 84

  10. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis

    Authors: , , , , , , , , , , - European Journal of Endocrinology 2013 cited by 407

  11. Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Naresh Aggarwal, Vincent Woo, Bruno St-Pierre, R Dumas, Irene Hramiak, Thomas G. Elliott, Troels Krarup Hansen, Jan Erik Henriksen, Jeppe Gram, Aina S. Lihn, Jens Meldgaard Bruun, Juha Saltevo, Jyrki Taurio, Jorma Strand, Timo T. Valle, Sakari Nieminen, Kirsi H. Pietiläinen, Bruno Guerci, Samy Hadjadj, Bertrand Cariou, Bruno Vergès, Sophie Borot, Alfred Penfornis, Diethelm Tschöpe, Thomas Schaum, Cornelia Marck, Thomas Horacek, Ludger Rose, Gerhard Klausmann, Joerg Luedemann, Steffi Appelt, Ulrich Aigner, R Goebel, Thomas Behnke, Anette‐Gabriele Ziegler, Eva Péterfai, Zsuzsanna Kerenyi, Tamás Oroszlán, G Kiss, L. Könyves, Gyorgyi Piros, Moshe Phillip, Ofri Mosenzon, Naim Shehadeh, Faiad Adawi, Julio Wainstein, Francesco Dotta, PierMarco Piatti, Stefano Genovese, Agostino Consoli, Paolo Di Bartolo, Edoardo Mannucci, Carla Giordano, Annunziata Lapolla, Carlos Aguilar, Alberto Esteban Bazzoni Ruiz, Guillermo Mondragon Ramirez, Emilia Pelayo Orozco, Carlos Alejandro Stobschinski de Alba, Carlos Eduardo Medina Pech, Jose Garza Ruiz, Leobardo Sauque Reyna, Guillermo Llamas Esperón, Luis Alejandro Nevarez Ruiz, Maricela Vidrio Velázquez, Fernando Flores Lozano, José Gerardo González‐González, Pedro Alberto García-Hernández, Roberto Araujo Silva, Efraín Villeda-Espinosa and 68 more - Diabetes Care 2018 cited by 238

  12. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials

    Authors: , , , , - Acta Diabetologica 2020 cited by 100

  13. Metabolic bariatric surgery as a therapeutic option for patients with type 2 diabetes: A meta‐analysis and network meta‐analysis of randomized controlled trials

    Authors: , , , , , , , , , , , , , - Diabetes Obesity and Metabolism 2023 cited by 45

  14. Efficacy and effects of bariatric surgery in the treatment of obesity: Network meta-analysis of randomized controlled trials

    Authors: , , , , - Nutrition Metabolism and Cardiovascular Diseases 2021 cited by 69

  15. Influenza: Diabetes as a risk factor for severe related-outcomes and the effectiveness of vaccination in diabetic population. A meta-analysis of observational studies

    Authors: , , , , , , , , - Nutrition Metabolism and Cardiovascular Diseases 2023 cited by 53

  16. Glucagon‐like peptide 1 ( GLP1 ) receptor agonists and risk for ischemic optic neuropathy: A meta‐analysis of randomised controlled trials

    Authors: , , , - Diabetes Obesity and Metabolism 2024 cited by 42

  17. Glucagon‐like peptide‐1 receptor agonists and mental health: A meta‐analysis of randomized controlled trials

    Authors: , , , - Diabetes Obesity and Metabolism 2024 cited by 30

  18. Diagnostic Crossover and Outcome Predictors in Eating Disorders According to DSM-IV and DSM-V Proposed Criteria: A 6-Year Follow-Up Study

    Authors: , , , , , , - Psychosomatic Medicine 2011 cited by 298

  19. Efficacy and safety of sodium glucose co‐transport‐2 inhibitors in type 2 diabetes: a meta‐analysis of randomized clinical trials

    Authors: , , - Diabetes Obesity and Metabolism 2013 cited by 279

  20. Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: An updated meta-analysis of randomized controlled trials

    Authors: , , , , , - Nutrition Metabolism and Cardiovascular Diseases 2020 cited by 81

  21. Body mass index (BMI), waist circumference (WC), waist-to-height ratio (WHtR) e waist body mass index (wBMI): Which is better?

    Authors: , , , , , - Endocrine 2022 cited by 61

  22. Type 1 diabetes and periodontitis: prevalence and periodontal destruction—a systematic review

    Authors: , , , , , , - Acta Diabetologica 2020 cited by 59

  23. Testosterone and Cardiovascular Risk: Meta-Analysis of Interventional Studies

    Authors: , , , , , - The Journal of Sexual Medicine 2018 cited by 133

  24. Perspectives in GLP-1 Research: New Targets, New Receptors

    Authors: , , - Trends in Endocrinology and Metabolism 2016 cited by 90